| 000 | 01313 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515085057.0 | ||
| 264 | 0 | _c20080227 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a0954-0121 | ||
| 024 | 7 |
_a10.1080/09540120701335238 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBeaston-Blaakman, A | |
| 245 | 0 | 0 |
_aCost-effectiveness of clinical interventions for AIDS wasting. _h[electronic resource] |
| 260 |
_bAIDS care _cSep 2007 |
||
| 300 |
_a996-1001 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnabolic Agents _xeconomics |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 |
_aBoston _xepidemiology |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Wasting Syndrome _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNutritional Physiological Phenomena |
| 650 | 0 | 4 |
_aOxandrolone _xeconomics |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xeconomics |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aShepard, D S | |
| 700 | 1 | _aStone, N | |
| 700 | 1 | _aShevitz, A H | |
| 773 | 0 |
_tAIDS care _gvol. 19 _gno. 8 _gp. 996-1001 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/09540120701335238 _zAvailable from publisher's website |
| 999 |
_c17379575 _d17379575 |
||